Towards Bioprinting Industrialization
Fabien Guillemot,
CEO,
Université Victor Segalen Bordeaux 2
Bioprinting has been defined as “the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies”.
From a technological point of view, different bioprinting technologies have been developed so far. Recently, Laser-Assisted Bioprinting (LAB) technology has emerged as an alternative method to inkjet and bioextrusion methods, thereby overcoming some of their limitations (namely clogging of print heads or capillaries) to pattern living cells and biomaterials with a micron-scale resolution and high cell viability.
During this presentation, we will present current development on the industrialization of bioprinting process, namely in the context of manufacturing 3D skin models.
|
|
